Clik here to view.
Baxter touts study indicating cost savings with Revaclear dialyzer
Baxter (NYSE:BAX) today released results from a study of its Revaclear high-flux dialyzer, touting lower use of erythropoiesis-stimulating agent with the filter. Use of the Revaclear dialyzer was...
View ArticleClik here to view.
Amgen 2nd-quarter profit tops Street view, raises 2016 forecast
(Reuters) – Amgen (NSDQ:AMGN) on Wednesday reported higher-than-expected 2nd-quarter profit on increased sales of its blockbuster rheumatoid arthritis drug Enbrel and newer medicines, and the company...
View ArticleClik here to view.
Pixium Vision wins CE Mark for Iris II retinal prosthesis
French retinal implant maker Pixium Vision said Monday it won CE Mark approval in the European Union for its Iris II bionic vision system designed for individuals with vision loss from outer retinal...
View ArticleClik here to view.
Companion Medical wins FDA nod for InPen insulin pen
Companion Medical said today it won FDA 510(k) approval for its wireless-enabled InPen insulin pen and mobile application. The InPen is designed to connect to smartphones via bluetooth and send data...
View ArticleClik here to view.
Hologic posts beat-and-raise 3rd quarter earnings
Hologic (NSDQ:HOLX) today released 3rd quarter earnings that topped analyst’s expectations, raising its outlook for the rest of the year in response. The Marlborough, Mass.-based company reported...
View ArticleClik here to view.
US regulators recommend “codevelopment” approach for IVD companion Dx products
By Stewart Eisenhart, Emergo Group The US Food and Drug Administration is recommending steps for both manufacturers and its own staff regarding contemporaneous market authorization for therapeutic...
View ArticleClik here to view.
New crop of robots to vie for space in the operating room
(Reuters) – Even though many doctors see need for improvement, surgical robots are poised for big gains in operating rooms around the world. Within 5 years, 1 in 3 U.S. surgeries – more than double...
View ArticleClik here to view.
Boston Scientific Q2 meets the street as sales grow
Boston Scientific (NYSE:BSX) today reported 2nd quarter earnings that met the Street’s expectations and saw overall sales grow over 15% from last year, sending shares up lightly in pre-market trading....
View ArticleClik here to view.
Zimmer Biomet shares lift after reporting big gains in sales
Zimmer Biomet (NYSE:ZBH) shares have risen nearly 5% after releasing solid 2nd quarter earnings, beating the street on earnings per share and seeing sales swell 65.6% compared to last year. The Warsaw,...
View ArticleClik here to view.
Varian Medical shares rise after Street-beating Q3
Varian Medical (NYSE:VAR) saw shares rise 5% after releasing 3rd quarter earnings that handily beat the Street’s expectations. The Palo Alto, Calif.-based company reported profits of $98.9 million, or...
View ArticleClik here to view.
Derma Sciences acquires BioD for $21.3m
Derma Sciences (NSDQ:DSCI) said today it is buying regenerative medicine developer BioD for $21.3 million up front, with the possibility of an additional $56.5 million. The deal between Princeton,...
View ArticleClik here to view.
Smith & Nephew touts 1st-use of Navio robotic-assisted knee system
A New York hospital is the 1st to use Smith & Nephew (NYSE:SNN) new robotics-assisted total knee replacement procedure following its recent 510(k) clearance from the FDA. The surgery took place at...
View ArticleClik here to view.
Critics of weight-loss device urge U.S. regulator to reverse approval
(Reuters) – Lotta Bosnyak takes extra time to chew the blueberries in her yogurt. Otherwise, she said, the device she credits with saving her life will not work. The tube Bosnyak is referring to has...
View ArticleClik here to view.
Abiomed posts solid Q1, lifts full year outlook
Abiomed (NSDQ:ABMD) lifted its revenue guidance for the year after posting a Street-beating 1st quarter today. The Danvers, Mass.-based company reported profits of $12.9 million, or 29¢ per share, on...
View ArticleClik here to view.
Merit Medical Q2 beats on EPS, misses on rev
Merit Medical (NSDQ:MMSI) today released its 2nd quarter earnings, beating the Street on earnings per share but falling short on revenue. The South Jordan, Utah-based company reported profits of $7.3...
View ArticleClik here to view.
Auris Surgical Robotics closes $80m Hansen Medical buy
Hansen Medical (NSDQ:HNSN) said today it completed its $80 million merger with Auris Surgical Robotics, which won approval from shareholders last week. Through the merger agreement, Auris paid $4 per...
View ArticleClik here to view.
Penumbra touts stent retriever study data
Penumbra (NYSE:PEN) said a 198-patient trial of its next-generation stroke-treatment device along with another company product showed promise, meeting primary endpoints. Results were positive enough...
View ArticleClik here to view.
MassDevice.com +5 | The top 5 medtech stories for July 28, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View ArticleClik here to view.
Orthofix wins Japanese regulatory win for Phoenix spinal fixation system
Orthofix (NSDQ:OFIX) said today it won regulatory approval from the Japanese Ministry of Health, Labor and Wellfare for its Phoenix minimally invasive spinal fixation system. The Phoenix system allows...
View ArticleClik here to view.
Heartware Q2 sees losses shrink, beats the street
HeartWare International (NSDQ:HTWR) today released 2nd quarter earnings that beat the Street alongside shrinking losses as the company is slated to be picked up Medtronic (NYSE:MDT) in a $1.1 billion...
View Article